Participants 152 184 3
patients with malignant neoplasm
Participants 260 286 4
control group, 30 patients
Participants 338 362 3
N-CWS group, 26 patients
Participants 404 474 7
55 patients with malignant pleural effusion due to primary lung cancer
Participants 857 913 4
Twenty-four patients with malignant pericardial effusion
